Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2838025 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Ubiquitin-Conjugating Enzyme E2I (UBE2I) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, followed by dialysis against PBS.
- Reactivity
- Human, Mouse
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 67AT1273-95-90
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references TRIM5α is a SUMO substrate.
The SUMOylation of matrix protein M1 modulates the assembly and morphogenesis of influenza A virus.
Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues.
Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.
Association of SUMO1 and UBC9 genotypes with tumor response in non-small-cell lung cancer treated with irinotecan-based chemotherapy.
Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: a genetic association study.
Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9.
Dutrieux J, Portilho DM, Arhel NJ, Hazan U, Nisole S
Retrovirology 2015 Mar 24;12:28
Retrovirology 2015 Mar 24;12:28
The SUMOylation of matrix protein M1 modulates the assembly and morphogenesis of influenza A virus.
Wu CY, Jeng KS, Lai MM
Journal of virology 2011 Jul;85(13):6618-28
Journal of virology 2011 Jul;85(13):6618-28
Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues.
Moschos SJ, Jukic DM, Athanassiou C, Bhargava R, Dacic S, Wang X, Kuan SF, Fayewicz SL, Galambos C, Acquafondata M, Dhir R, Becker D
Human pathology 2010 Sep;41(9):1286-98
Human pathology 2010 Sep;41(9):1286-98
Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.
Zhu S, Sachdeva M, Wu F, Lu Z, Mo YY
Oncogene 2010 Mar 25;29(12):1763-72
Oncogene 2010 Mar 25;29(12):1763-72
Association of SUMO1 and UBC9 genotypes with tumor response in non-small-cell lung cancer treated with irinotecan-based chemotherapy.
Han JY, Lee GK, Yoo SY, Yoon SJ, Cho EY, Kim HT, Lee JS
The pharmacogenomics journal 2010 Apr;10(2):86-93
The pharmacogenomics journal 2010 Apr;10(2):86-93
Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: a genetic association study.
Ahn K, Song JH, Kim DK, Park MH, Jo SA, Koh YH
Neuroscience letters 2009 Nov 20;465(3):272-5
Neuroscience letters 2009 Nov 20;465(3):272-5
Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9.
Fradet-Turcotte A, Brault K, Titolo S, Howley PM, Archambault J
Virology 2009 Dec 20;395(2):190-201
Virology 2009 Dec 20;395(2):190-201
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB